Volume 8.02 | Jan 19

Mesenchymal Cell News 8.02 January 19, 2016
Mesenchymal Cell News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook   MESCN on Twitter
SIRT6 Safeguards Human Mesenchymal Stem Cells from Oxidative Stress by Coactivating NRF2
Researchers generated SIRT6 knockout human mesenchymal stem cells (hMSCs) by targeted gene editing. SIRT6-deficient hMSCs exhibited accelerated functional decay, a feature distinct from typical premature cellular senescence. [Cell Res] Full Article
Watch Video MesenTrek Rise of Enriched Mouse MSC Cultures
PUBLICATIONS (Ranked by impact factor of the journal)

Mesenchymal Stem Cells Inhibit Transmission of α-Synuclein by Modulating Clathrin-Mediated Endocytosis in a Parkinsonian Model
Using α-synuclein-enriched models, scientists showed that mesenchymal stem cells inhibited α-synuclein transmission by blocking the clathrin-mediated endocytosis of extracellular α-synuclein via modulation of the interaction with N-methyl-D-aspartate receptors, which led to a prosurvival effect on cortical and dopaminergic neurons with functional improvement of motor deficits in α-synuclein-enriched models. [Cell Rep]
Full Article | Graphical Abstract

Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via NFkB Signaling
Investigators probed the proteome of mesenchymal stem cells (MSCs) and MSC derived exosomes from cells cultured under expansion conditions and under ischemic tissue simulated conditions to elucidate key angiogenic paracrine effectors present and potentially differentially expressed in these conditions. [Stem Cells]
Abstract | Full Article

Interferon-Gamma Improves Impaired Dentinogenic and Immunosuppressive Functions of Irreversible Pulpitis-Derived Human Dental Pulp Stem Cells
Scientists examined the stem cell potency of dental pulp stem cells isolated from diseased teeth with irreversible pulpitis (IP-DPSCs). In comparison with healthy DPSCs, IP-DPSCs expressed lower colony-forming capacity, population-doubling rate, cell proliferation, multipotency, in vivo dentin regeneration, and immunosuppressive activity, suggesting that intact IP-DPSCs may be inadequate for dentin/pulp regeneration. [Sci Rep] Full Article

Low Oxygen Tension Modulates the Insulin-Like Growth Factor -1 or -2 Signaling via Both Insulin-Like Growth Factor-1 Receptor and Insulin Receptor to Maintain Stem Cell Identity in Placental Mesenchymal Stem Cells
In preterm placental mesenchymal stem cells, low oxygen tension increased the expression of insulin like growth factor (IGF)-2 and reduced IGF-1. IGF-1 stimulated higher phosphorylation of IGF-1Rβ, ERK1/2 and AKT, which was maintained at steady lower levels by low oxygen tension. [Endocrinology] Abstract

MicroRNA-23a Inhibits Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by Targeting LRP5
The authors investigated the role of microRNA (miR)-23a in bone marrow-derived mesenchymal stem cells osteogenesis. They revealed that miR-23a was significantly downregulated during osteogenic differentiation. [Int J Biochem Cell Biol] Abstract

Stroke Serum Priming Modulates Characteristics of Mesenchymal Stromal Cells by Controlling the Expression miRNA-20a
The authors investigated microRNA (miR) profiling in stroke serum primed mesenchymal stem cells (MSCs) and tested whether the regulation of certain miRs may affect the proliferation rate of rat MSCs. [Cell Transplant] Full Article

Immunomodulatory Effect of Mesenchymal Stem Cells on the Immune Response of Macrophages Stimulated by Aspergillus fumigatus Conidia
The authors evaluated the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on the mesenchymal stem cell (MSC)-related cytokine response and fungal growth. As a results, after conidia stimulation, tumor necrosis factor-α was down-regulated and interleukin-10 was up-regulated in MSC-treated J774A.1 cells when compared to J774A.1 cells alone. [Med Mycol] Abstract


Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells toward Hepatocellular Carcinoma
Orthotopic animal models of hepatocellular carcinoma (HCC) were established to investigate the role of CCL15 in human mesenchymal stem cells (hMSCs) migration toward HCC in vivo. Both histological and flow cytometric analysis showed that significantly fewer hMSCs localized within 97H-CCL15-shRNA xenografts compared with 97H-green fluorescent protein xenografts after intravenous delivery. [Stem Cells] Abstract

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-Derived Neurotrophic Factor Improve Outcomes in Huntington’s Disease Mouse Models
Double-blinded studies were performed to examine the effects of intrastriatally transplanted human mesenchymal stem cell/brain-derived neurotrophic factor on disease progression in two strains of immune suppressed Huntington’s disease transgenic mice. [Mol Ther] Abstract | Full Article

Mesenchymal Stem Cell Transplantation Inhibited High Salt-Induced Activation of the NLRP3 Inflammasome in the Renal Medulla in Dahl S Rats
Investigators determined the response of the NLRP3 inflammasome to high salt intake and the effect of mesenchymal stem cell transplantation on the NLRP3 inflammasome in the renal medulla in Dahl salt sensitive (S) rats. [Am J Physiol Renal Physiol] Abstract

Download Mini-Review: Myogenic Progenitor and Satellite Cells
P53 Functional Abnormality in Mesenchymal Stem Cells Promotes Osteosarcoma Development
The authors first explain the determinant function of p53 in osteosarcoma development. They then summarize the role of p53 in monitoring mesenchymal stem cell (MSC) fidelity and in regulating MSC differentiation programs during osteogenesis. Finally, they discuss the importance of loss of p53 function in tissue microenvironment. [Cell Death Dis] Full Article

Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field.

Perinatal Stem Cell Society 2016
GE Healthcare, FedDev Ontario Commit CAD $40 Million for New CCRM-Led Center to Solve Cell Therapy Manufacturing Challenges
GE Healthcare, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and the Center for Commercialization of Regenerative Medicine (CCRM) are building a center for advanced therapeutic cell technologies in Toronto with an investment of $40 million from GE and FedDev Ontario. [Center for Commercialization of Regenerative Medicine] Press Release

Regeneus’ Progenza Stem Cell Therapy Clears Initial Safety Review
Regeneus’ off-the-shelf allogeneic stem cell treatment for knee osteoarthritis, Progenza, has enhanced its potential for commercialization for the company after an encouraging review of safety data from an oversight committee in early trialing. The regenerative medicine technology received no safety concerns after trialing with its first cohort of ten patients in the trial. [Regeneus Ltd.] Press Release

From our sponsor:
Interested in assays for human mammary stem and progenitor cells?
Request your free wallchart.
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
NEW Stem Cell Summit 2016
April 25-27, 2016
Boston, United States

Visit our events page to see a complete list of events in the mesenchymal cell community.
NEW Tenure-Track Faculty Positions – Assistant/Associate/Full Professor (Nanyang Technological University)

NEW Postdoctoral Positions – Regenerative Biology and Medicine (Helmholtz Zentrum München)

Development Engineer/Scientist – Cell and Gene Therapy and Regenerative Medicine (Centre for Commercialization of Regenerative Medicine)

Project Manager – Neurodegeneration and Stem Cell Science (Université du Luxembourg)

Postdoctoral Research Associate – Developmental and Stem Cell Biology (University of Cambridge)

Postdoctoral Fellow – Cell Therapy (Toronto Western Hospital)

Stem Cell Scientist and Postdoctoral Positions (National Center for Advancing Translational Science)

PhD Studentship – Aging Research (Cologne Graduate School of Aging Research)

Doctoral Fellow – Stem Cell Research (Uniklinik Koln)

Postdoctoral Fellow – Stem Cell Biology/Genome Engineering (Amgen)

Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Mesenchymal Cell News: Archives | Events | Contact Us